Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 1 Demographic data of the two studied groups: Showing significant increase in all laboratory findings and Larsen score and significant decrease in DEXA score in rheumatoid patients as compared with controls by using t test

From: Do anti-carbamylated protein antibodies in rheumatoid arthritis reflect local and systemic osteoporosis? A study of osteoprotegrin and receptor activator for nuclear factor kappa B ligand and radiological assessment

 

RA patients

(n=80)

Controls

(n=40)

Demographic parameters

 Age, years

46.76 ± 10.03

44.66 ± 7.22

 Female, no. (%)

71 (88.8)

34 (85)

Clinical parameters

 Duration of disease (years)

3.5 ±3.4

 

 DAS28 score

3.64 ± 1.16

 

 HAQ score

1.83 ± 0.63

 

Laboratory parameters (mean ±SD)

 ESR, (mm/h)

45.4 ± 12.4*

10.20±3.49

 CRP (mg/dL)

10.9 ±8.3*

3.8±1.85

 RF (IU/mL)

90.63 ± 128.61*

6± 1.4

 Anti-CCP (units/mL)

98.25 ± 143.98*

10± 4.4

 Anti-CarP

135.31±16.48*

30.54 ±11.12

 OPG

316± 487*

76±94

 RANKL

3.72 ± 0.43*

2.34 ±50.1

DEXA score

 LS

−2.24 ± 0.22*

1.04 ± 0.32

 TH

−2.80 ± 8.29*

−1.24 ± 0.22

 Forearm

−2.94 ± 9.82*

−1.24 ± 0.22

Modified Larsen score

31.9 ± 11.2

11.8 ± 12.2

  1. *t test is used and significance P ≤ 0.05
  2. Values are expressed as mean ± standard deviation (SD) or no. and %
  3. DAS28 disease activity for 28 joint indices score, HAQ Health Assessment Questionnaire, ESR erythrocyte sedimentation rate, CRP C-reactive protein, RF rheumatoid factor, Anti-CCP anti-cyclic citrullinated peptide
Back to article page